0001171843-16-007888.txt : 20160216 0001171843-16-007888.hdr.sgml : 20160215 20160216060021 ACCESSION NUMBER: 0001171843-16-007888 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160216 FILED AS OF DATE: 20160216 DATE AS OF CHANGE: 20160216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lombard Medical, Inc. CENTRAL INDEX KEY: 0001597426 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36402 FILM NUMBER: 161422414 BUSINESS ADDRESS: STREET 1: LOMBARD MEDICAL HOUSE STREET 2: 4 TRIDENT PARK, BASIL HILL ROAD CITY: DIDCOT, OXFORDSHIRE STATE: X0 ZIP: OX11 7HJ BUSINESS PHONE: 1 345 949 1040 MAIL ADDRESS: STREET 1: CODAN TRUST COMPANY (CAYMAN) LIMITED STREET 2: CRICKET SQUARE, HUTCHINS DRIVE CITY: PO BOX 2681, GRAND CAYMAN STATE: E9 ZIP: KY1-1111 6-K 1 f6k_021616.htm FORM 6-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________

Form 6-K
_______________________

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

February 16, 2016
_______________________________

Lombard Medical, Inc.
(Exact Name of Registrant as Specified in Its Charter)
_______________________________

N/A
(Translation of Registrant’s Name into English)
_______________________________

Cayman Islands	3841	Not applicable
(State or Other Jurisdiction of Incorporation or Organization)	(Primary Standard Industrial Classification Code Number)	(I.R.S. Employer Identification Number)

6440 Oak Canyon
Suite 200
Irvine, CA 92618
+866-790-1447
(Address, Including ZIP Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)

_______________________________

Lombard Medical, Inc.
6440 Oak Canyon
Suite 200
Irvine, CA 92618
(Name, Address of Agent for Service)

_______________________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ] Form 40-F [ ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Furnished as Exhibit 99.1 to this Report on Form 6-K is a press release of Lombard Medical, Inc. dated February 16, 2016, announcing that it will release its 2015 fourth quarter and year-end financial results before the market opens on Monday, February 22, 2016. In conjunction with the release, the Company will host a conference call with the investment community at 10:30 a.m. Eastern Time on Monday, February 22, 2016, to discuss the financial results and other business developments.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Lombard Medical, Inc.



Date: February 16, 2016	By:	/s/ William J. Kullback
		William J. Kullback
		Chief Financial Officer

EX-99.1 2 exh_991.htm EXHIBIT 99.1 EdgarFiling

EXHIBIT 99.1

Lombard Medical Announces 2015 Fourth Quarter and Year-End Financial Results Release and Conference Call Date

IRVINE, Calif., Feb. 16, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that it will release its 2015 fourth quarter and year-end financial results before the market opens on Monday, February 22, 2016. In conjunction with the release, the Company will host a conference call with the investment community at 10:30 a.m. Eastern Time on Monday, February 22, 2016, to discuss financial results and provide a business update.

Interested parties may access the live call via telephone by dialing 1-877-407-4018 (domestic), 0800-756-3429 (UK toll free) or 1-201-689-8471 (international). To listen to the live call via Lombard’s website, go to www.lombardmedical.com, in the Events and Presentations section. A webcast replay of the call will be available following the conclusion of the call in the Events and Presentations section of the website.

About Lombard Medical, Inc.
Lombard Medical, Inc. is an Irvine, CA-based medical device company focused on the $1.7bn market for minimally invasive treatment of abdominal aortic aneurysms (AAAs). The Company has global regulatory approval for Aorfix™, an endovascular stent graft which has been specifically designed to treat patients with the broadest range of AAA anatomies, including aortic neck angulation up to 90 degrees. The Company has also achieved CE Mark for the Altura™ endograft system, an innovative ultra-low profile endovascular stent graft that offers a simple and predictable solution for the treatment of more standard AAA anatomies. Altura was launched in Europe in January 2016, with an international rollout planned for later in 2016. For more information, please visit www.lombardmedical.com.

For further information:

Lombard Medical, Inc.
Simon Hubbert, Chief Executive Officer
William J. Kullback, Chief Financial Officer

Tel: +1 949 379 3750 / +44 (0)1235 750 800
Tel: +1 949 748 6764